abrdn Life Sciences Investors - SH BEN INT (HQL)

Q4 2023 13F Portfolio Holders as of 12/31/2023

Type / Class
Equity / SH BEN INT
Number of holders
78
Total Shares
7.94M
Shares change
+1.51M
Total reported value, excl. options
$107M
Value change
+$20.4M
Put/Call ratio
0
Number of buys
38
Number of sells
-33
Price
$13.46
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.